Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Autor: Tiberi S; Division of Infection, Barts Healthcare NHS Trust, London, UK These authors contributed equally to this work., Sotgiu G; Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy These authors contributed equally to this work., D'Ambrosio L; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland These authors contributed equally to this work., Centis R; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy These authors contributed equally to this work., Abdo Arbex M; University Center of Araraquara, Sao Paulo, Brazil Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, Brazil., Alarcon Arrascue E; International Union against Tuberculosis and Lung Disease (The Union), Lima, Peru MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France., Alffenaar JW; University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands., Caminero JA; MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France Pneumology Dept, Hospital General de Gran Canaria 'Dr. Negrin', Las Palmas de Gran Canaria, Spain., Gaga M; MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, Greece., Gualano G; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', Rome, Italy., Skrahina A; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Solovic I; National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, Slovakia., Sulis G; University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination - University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy., Tadolini M; Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy., Alarcon Guizado V; National Tuberculosis Control Programme, Ministry of Health, Lima, Peru., De Lorenzo S; AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy., Roby Arias AJ; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador., Scardigli A; MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France., Akkerman OW; University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis; TB Center Beatrixoord, Groningen, The Netherlands., Aleksa A; Educational Institution 'Grodno State Medical University', Grodno, Belarus., Artsukevich J; Educational Institution 'Grodno State Medical University', Grodno, Belarus., Auchynka V; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Bonini EH; University Center of Araraquara, Sao Paulo, Brazil Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, Brazil., Chong Marín FA; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador., Collahuazo López L; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador., de Vries G; KNCV Tuberculosis Foundation, The Hague, The Netherlands., Dore S; Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy., Kunst H; Dept of Respiratory Medicine, Queen Mary University, London, UK., Matteelli A; University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination - University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy., Moschos C; MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, Greece., Palmieri F; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', Rome, Italy., Papavasileiou A; MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, Greece., Payen MC; Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium., Piana A; Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy., Spanevello A; Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy., Vargas Vasquez D; National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, Peru., Viggiani P; AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy., White V; Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UK., Zumla A; Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK., Migliori GB; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.

Publikováno v: The European respiratory journal [Eur Respir J] 2016 Jun; Vol. 47 (6), pp. 1758-66. Date of Electronic Publication: 2016 Apr 13.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB.

Autor: Tiberi S; Division of Infection, Barts Healthcare NHS Trust, London, UK These authors contributed equally to this work., Payen MC; Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium These authors contributed equally to this work., Sotgiu G; Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy These authors contributed equally to this work., D'Ambrosio L; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland These authors contributed equally to this work., Alarcon Guizado V; National Tuberculosis Control Programme, Ministry of Health, Lima, Peru., Alffenaar JW; Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Abdo Arbex M; University Center of Araraquara, Sao Paulo, Brazil Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, Brazil., Caminero JA; Pneumology Dept, Hospital General de Gran Canaria 'Dr. Negrin', Las Palmas de Gran Canaria, Spain MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France., Centis R; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy., De Lorenzo S; AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy., Gaga M; MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, Greece., Gualano G; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', Rome, Italy., Roby Arias AJ; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador., Scardigli A; MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France., Skrahina A; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Solovic I; National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Slovakia., Sulis G; University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination - University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy., Tadolini M; Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy., Akkerman OW; Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Alarcon Arrascue E; MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France International Union Against Tuberculosis and Lung Disease (The Union), Lima, Peru., Aleska A; Educational Institution 'Grodno State Medical University', Grodno, Belarus., Avchinko V; Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Bonini EH; University Center of Araraquara, Sao Paulo, Brazil Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, Brazil., Chong Marín FA; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador., Collahuazo López L; National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, Ecuador., de Vries G; KNCV Tuberculosis Foundation, The Hague, The Netherlands., Dore S; Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy., Kunst H; Dept of Respiratory Medicine, Queen Mary University, London, UK., Matteelli A; University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination - University of Brescia and Brescia Spedali Civili General Hospital, Brescia, Italy., Moschos C; MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, Greece., Palmieri F; Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases 'L. Spallanzani', Rome, Italy., Papavasileiou A; MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, Greece., Spanevello A; Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy Dept of Clinical and Experimental Medicine, University of Insubria, Varese, Italy., Vargas Vasquez D; National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, Peru., Viggiani P; AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, Italy., White V; Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UK., Zumla A; Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UK., Migliori GB; WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.

Publikováno v: The European respiratory journal [Eur Respir J] 2016 Apr; Vol. 47 (4), pp. 1235-43. Date of Electronic Publication: 2016 Mar 10.